Inventor
PICKWORTH MARK
GB39 patents
⚠️ This page may combine multiple inventors who share the name “PICKWORTH MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HEPTARES THERAPEUTICS LTD
35 patentsUS9670183B2Jun 6, 2017
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD34 citations98
US10961225B2Mar 30, 2021
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD11 citations94
US10689368B2Jun 23, 2020
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD12 citations94
US10196380B2Feb 5, 2019
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD20 citations94
US9926297B2Mar 27, 2018
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD19 citations94
US9758506B2Sep 12, 2017
Muscarinic agonists
HEPTARES THERAPEUTICS LTD22 citations94
US10030035B2Jul 24, 2018
Muscarinic receptor agonists
HEPTARES THERAPEUTICS LTD14 citations93
US9669013B2Jun 6, 2017
Bicyclic aza compounds as muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD14 citations93
US9266857B2Feb 23, 2016
Bicyclic AZA compounds as muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD23 citations93
US10385039B2Aug 20, 2019
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists
HEPTARES THERAPEUTICS LTD13 citations92
US11324738B2May 10, 2022
Muscarinic agonists
HEPTARES THERAPEUTICS LTD9 citations86
US11254656B2Feb 22, 2022
Muscarinic agonists
HEPTARES THERAPEUTICS LTD10 citations86
US11091456B2Aug 17, 2021
Muscarinic agonists
HEPTARES THERAPEUTICS LTD10 citations86
US11034704B2Jun 15, 2021
Muscarinic receptor agonists
HEPTARES THERAPEUTICS LTD10 citations86
US11014880B2May 25, 2021
Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD9 citations86
US10759751B2Sep 1, 2020
Substituted spirocyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD12 citations86
US10548884B2Feb 4, 2020
Muscarinic agonists
HEPTARES THERAPEUTICS LTD11 citations86
US10738029B2Aug 11, 2020
Muscarinic agonists
HEPTARES THERAPEUTICS LTD12 citations85
US10428088B2Oct 1, 2019
Muscarinic receptor agonists
HEPTARES THERAPEUTICS LTD11 citations84
US10351545B2Jul 16, 2019
Muscarinic agonists
HEPTARES THERAPEUTICS LTD10 citations84
US10259787B2Apr 16, 2019
Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD13 citations84
US10259802B2Apr 16, 2019
Bicyclic aza compounds as muscarinic M1 receptor antagonists
HEPTARES THERAPEUTICS LTD9 citations84
US10167272B2Jan 1, 2019
Muscarinic agonists
HEPTARES THERAPEUTICS LTD11 citations84
US10167284B2Jan 1, 2019
Spirocyclic compounds as agonists of the muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD12 citations84
US9975890B2May 22, 2018
Bicyclic AZA compounds as muscarinic M1 receptor antagonists
HEPTARES THERAPEUTICS LTD10 citations84
US9925178B2Mar 27, 2018
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD4 citations83
US9808457B2Nov 7, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD6 citations83
US9688660B2Jun 27, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD5 citations83
US11834407B2Dec 5, 2023
Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD5 citations75
US12024499B2Jul 2, 2024
Muscarinic agonists
HEPTARES THERAPEUTICS LTD2 citations72
US10888561B2Jan 12, 2021
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10300056B2May 28, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10259812B2Apr 16, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10166226B2Jan 1, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD3 citations72
US9802935B2Oct 31, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD4 citations72
NXERA PHARMA UK LTD
4 patentsUS12215099B2Feb 4, 2025
Quinolinone and benzoxazine derivatives as muscarinic M1 and/or M4 receptor agonists
NXERA PHARMA UK LTD0 citations62
US12202843B2Jan 21, 2025
Muscarinic receptor agonists
NXERA PHARMA UK LTD0 citations62
US12234227B2Feb 25, 2025
Pyrazole derivatives as H4 antagonist compounds
NXERA PHARMA UK LTD0 citations61
US12178813B2Dec 31, 2024
CGRP receptor antagonists
NXERA PHARMA UK LTD0 citations61